Pfizer opens anti neocrown generic drugs for low - and middle-income countries! Experts say the vaccine should also be opened.Pfizer's official website released Pfizer will sign a voluntary license agreement against COVID-19's oral drug candidate PF-07321332 in Geneva in November 16th. According to the agreement, the world's qualified generic drug manufacturers can produce PF-07321332 drugs to 95 countries, covering about 53% of the world's population
On December 7, the African Institute of health released information that the neutralizing antibody titer against Omicron variant in two doses of Pfizer vaccine was 41 times lower than that of the original strain, which attracted global attention. Pfizer released similar data the next day, saying that the antibody titer decreased 25 times, and two doses of vaccine may not be enough to prevent Omicron infection.